Latest Medication News

  • For more information on all medications available in UMMC, please click here.
  • For procedures on how to request to include medication into UMMC's Formulary, please click here.
  • All displayed images are for illustration purpose only.

Implementation of New Standard Outpatient Medication Charges

posted Oct 20, 2017, 12:27 AM by Izam Ezri Mohd Zakaria   [ updated Oct 20, 2017, 12:38 AM ]

20th October 2017 (Circular NO. SP PPUM:  389/2017):

Effective from 01st November 2017, new fees for supply of Standard Outpatient Medications will be charged in line with the decision made by UMMC's Board of Directors on 08th August 2017.
Image courtesy of Money Crashers website

The basic charge for supply of Standard Outpatient Medications from 01st November 2017 onwards will be as follows:

 One (1) Week

 Two (2) Weeks

 Four (4) Weeks /
One (1) Month

Please take note, thank you!

Guidelines for Use of Idarucizumab injection in UMMC

posted Oct 19, 2017, 9:17 PM by Izam Ezri Mohd Zakaria   [ updated Oct 19, 2017, 9:35 PM ]

19th October 2017 (Circular NO. SP PPUM: 380/2017):

Idarucizumab 2.5g (Praxbind) Injection has been approved by UMMC's Drugs & Therapeutics Sub-Committee in July 2017 as a Standard Formulary Medication in UMMC.
It is a potential life-saving medication that reverses the action of the oral anti-coagulant medication, Dabigatran.

Idarucizumab is meant for use in:
  • Life-threatening / uncontrolled bleeding OR
  • When emergency surgery / procedures are required
for patients currently on Dabigatran.

A Cardiology Consultant or Lecturer must be consulted for every case prior to Idarucizumab therapy.

The recommended dosage is 5g (2 vials) intravenously over 10 minutes

Supply of Idarucizumab is kept at Emergency Pharmacy and only TWO (2) sets of 2 vials can be made available per year due to its very high cost.

Please refer to the chart below for easy referencing.

Medication Recall- Morphine HCL Mixture 2mg/mL (200mL)

posted Oct 19, 2017, 1:27 AM by Izam Ezri Mohd Zakaria   [ updated Oct 19, 2017, 1:33 AM ]

17th October 2017 (Circular NO. SP PPUM: 379/2017): 

Due to detection of unidentified foreign particles in our in-house product, UMMC Pharmacy is initiating a voluntary recall of the following medication:

1) Morphine HCL Mixture 2mg/mL (200mL)
   Batch Number: MN170710009
    Expiry Date: 06 January 2018

2) Morphine HCL Mixture 2mg/mL (200mL)
    Batch Number: MN170725007
    Expiry Date: 21 January 2018

Wards are advised to return all stocks from the stated production batches to Inpatient Pharmacy while Outpatients may do so at any of our Pharmacy counters.

Your kind cooperation in this matter is highly appreciated.
Thank you!

Medication Supply- Limitation for Oral Diazepam Tablet

posted Oct 16, 2017, 7:30 PM by Izam Ezri Mohd Zakaria   [ updated Oct 16, 2017, 7:43 PM ]

13th October 2017 (Circular NO. SP PPUM: 368/2017):

UMMC's current supplier has reached its limit for supplying oral Diazepam Tablet set by the Malaysian Ministry of Health on Psychotropic Medications.
Diazepam ball & stick figure and chemical structure images by courtesy of Wikipedia

The supply is only expected to resume early in the year 2018.

Until that time, the doctors in UMMC is advised to prescribe oral Clonazepam Tablet as the alternative to oral Diazepam Tablet for patients needing this medication.

We deeply regret any inconveniences caused by the supply restrictions.

Discontinued Medication- Strontium Ranelate 2g Sachet

posted Oct 4, 2017, 12:10 AM by Izam Ezri Mohd Zakaria   [ updated Oct 4, 2017, 11:50 PM ]

4th October 2017 (Circular No. SP PPUM:  340/2017):

Servier had officially announced the decision to cease distribution of the following product:

Strontium Ranelate 2g Granules 

Brand: Protaxos
Form: Granules for oral suspension
Manufacturer: Les Laboratories Servier
Formulary Category: Special

Existing Standard Formulary medications, such as Alendronate 70mg Tablet and several others as recommended by the Malaysian Clinical Guidance on Management of Osteoporosis 2012 (revised 2015) as the alternative to this discontinued medication.

Osteoporosis Management Malaysia 2015

Discontinued Medication- Chloroquine Phosphate 250mg Tablet

posted Oct 3, 2017, 11:45 PM by Izam Ezri Mohd Zakaria   [ updated Oct 3, 2017, 11:55 PM ]

3rd October 2017 (Circular NO. SP PPUM:  ​3​66/2017):
Due to the high resistance rate to this medication and infrequent use, UMMC's Drugs and Therapeutics Sub-Committee has agreed, in its July 2017 meeting, to remove this medication from UMMC Formulary.

Chloroquine Phosphate 250mg Tablet

Form: Tablet
Formulary Category: Standard

The alternative to this medication for treating the same indication is the combination product Artemether 20mg + Lumefantrine 120mg (Riamet) tablet, a Standard Formulary medication.

Revision of Anti-Rejection Medication Subsidy

posted Oct 3, 2017, 9:12 PM by Izam Ezri Mohd Zakaria   [ updated Oct 3, 2017, 11:17 PM ]

28th August 2017 (Circular NO. SP PPUM:  316 /2017):
Beginning 1st November 2017, a revision in subsidy for supply of Anti-Rejection Medication in Kidney Transplant cases will take effect.

Each patient will be charged a nominal fee for one of the two types of Anti-Rejection Medication supplied.

This will ensure that all Kidney Transplant patients will be able to get a continuous supply of the medication in the long run.

For further enquiry, please refer to your Nephrology Specialists.

Use of Medication Delivery Bag to Transport Medications for Wards

posted Sep 26, 2017, 9:43 PM by Izam Ezri Mohd Zakaria   [ updated Sep 26, 2017, 9:56 PM ]

21st September 2017 (Circular NO. SP PPUM:   349/2017):
Beginning Wednesday, 27th September 2017, all Wards shall ensure that medications are transported to and from the Wards using the Medication Delivery Bag.

This is a Safety & Quality Assurance initiative by Pharmacy for securing medication delivery.

Each Ward has been assigned a designated quantity of Medication Delivery Bags for medications transport purpose and every Ward is also in charge of the Bag's safekeeping, cleanliness as well as maintenance.

Medication Delivery Bag Video

Pharmacy has the right to refuse supply if the Ward staff tasked with collecting medications from Pharmacy fails to produce the Medication Delivery Bag.

And upon delivery of medications by Pharmacy staff to Wards, an empty Bag shall be made ready for exchange by the Wards.
Otherwise, Pharmacy will have no Bag to use for the following delivery and is prevented from delivering medications.
This may result in delayed administration of patient's medication or even a missed dose.

The loss of a Bag shall be reported immediately to Pharmacy. As penalty, a suitable fee shall be imposed for Wards to replace their lost Medication Delivery Bag.

Should there be further enquiries, please feel free to call Inpatient Pharmacy at the following extensions:
  • General Line- 2384
  • Pharmacists Room- 2487
The cooperation from all Wards in making sure of the safe and secure delivery of medications within UMMC is very much appreciated.
Thank you!

Formulary Category Change - Esomeprazole

posted Sep 7, 2017, 5:30 PM by Chong Ching Wern   [ updated Sep 7, 2017, 5:40 PM ]

7th September 2017 (Circular No. SP PPUM: 322/2017):
Name of Medication: Esomeprazole 40 mg
Brand: Nexium
Form: Tablet, Injection
Company: Astra Zeneca
Formulary Category: Special Formulary

There will be a change in the formulary category for the drug Esomeprazole (Nexium) for both tablets and injections to Special Formulary.

What does Special Formulary means?
This means that if patients are being prescribed on this medications, they will have to purchase it from PharmUMMC or any other pharmacies which sell this medication. Further information can be obtained from here:

Is there any alternative to this medication?
Yes, our pharmacy can offer Omeprazole 20 mg Capsules and Pantoprazole 40 mg both Tablets and Injections as an alternative.
They are under the Standard Formulary and hence patients can obtain them from our UMMC's Pharmacy.
Pantoprazole 40 mg Tablets (Nexium)

Pantoprazole 40 mg Injection (Nexium)

Medication Brand Conversion - Zolpidem

posted Aug 24, 2017, 7:19 PM by Izam Ezri Mohd Zakaria   [ updated Oct 3, 2017, 7:02 PM ]

24th August 2017 (Circular No. SP PPUM:  309/2017):

UMMC will soon be supplying patients on oral Zolpidem with "Zopim" tablets by Taiwan Biotech Co. Ltd, Taiwan in place of "Stilnox" tablets by Sanofi-Aventis.

The previous restrictions for supply of this medication still applies.
Outpatient Pharmacy will only be able to supply to Government Servants / Pensioners and their dependants when prescribed by doctors of Psychological Medicine.
All other categories of patients will need to purchase this medication from PharmUMMC.

Zolpidem 10mg tablet (Zopim)

1-10 of 40